SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma

Xing Feng, Li Gao, Yonggang Xue, Yanbing Zhang, Hongyou Cao, Tianchang Wange

Open source

DOI
10.1615/critrevimmunol.2026062879
Published
2026
Container
Critical Reviews in Immunology
Publisher
Begell House
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1615/critrevimmunol.2026062879,
  title = {SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma},
  author = {Xing Feng and Li Gao and Yonggang Xue and Yanbing Zhang and Hongyou Cao and Tianchang Wange},
  year = {2026},
  journal = {Critical Reviews in Immunology},
  doi = {10.1615/critrevimmunol.2026062879},
  url = {https://doi.org/10.1615/critrevimmunol.2026062879}
}

RIS

TY  - JOUR
TI  - SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma
AU  - Xing Feng
AU  - Li Gao
AU  - Yonggang Xue
AU  - Yanbing Zhang
AU  - Hongyou Cao
AU  - Tianchang Wange
PY  - 2026
JO  - Critical Reviews in Immunology
DO  - 10.1615/critrevimmunol.2026062879
UR  - https://doi.org/10.1615/critrevimmunol.2026062879
ER  - 

APA

Feng, X., Gao, L., Xue, Y., Zhang, Y., Cao, H., & Wange, T. (2026). SLC2A1-Dependent Ketone Metabolism Regulates Tumor Progression and Immunotherapy Efficacy in Lung Adenocarcinoma. Critical Reviews in Immunology. https://doi.org/10.1615/critrevimmunol.2026062879

Source records